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In connection with studies on the rate and route of dispersal of small amounts 
of radiolabeled allergens--picryl chloride and dinitrochlorobenzene--from  intra- 
dermal ear sites (1), the result of extirpating the injected ears at various fixed 
times was explored with regard to its affecting the capacity to develop contact 
hypersensitivity to the chemical allergen in question. The plan was to differen- 
tiate between immunologic effects of (a) chemical which had already escaped 
from the ear site and (b) the remaining portion which remained fixed locally for 
many hours or even days. 
Experiments of a similar type, but based on epicutaneous absorption of chemi- 
cal allergens, had been undertaken by others.  Frey and Wenk (2-4)  extirpated 
sites on the flank of guinea pigs, on which 0.4--1.0 mg of 2:4 dinitrochloroben- 
zene  (DNCB)  had been  deposited  on a 3 mm area,  and studied the critical 
period for interrupting onset of sensitivity and the effect of removing draining 
lymph nodes; the fate of the applied chemical was not traced. Turk et al., in 
extensive studies (5-7), applied large amounts, 5-20 mg, of allergens to the ear 
and studied the effects of removal of the ear and of the draining node at various 
times,  as well as the cellular changes observed within the draining node. 1*C- 
labeled  dinitrofluorobenzene  (DNFB)  was also used (7)  in tracing resultant 
soluble dinitrophenyl-protein complexes in their passage through the lymphatic 
system. 
Our findings have been different. Sensitization could be prevented if the site of 
injection was excised many hours or days after the injection, much longer than 
the workers quoted above, yet the chemical was found to escape readily from the 
site of deposition via the local blood vessels, and surprisingly not via the lym- 
phatics. The differences in the pathways taken by chemical allergens and soluble 
proteins after intradermal injections appear to rest chiefly on the physicochemi- 
cal properties  of the allergenic chemicals such as molecular weight, lipid solu- 
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bility,  and  occurrence  of  fairly  slow  interactions  between  allergen  and  local 
tissue. Allergen escaping early from the intradermal site was  found to induce  a 
degree of specific tolerance to later deliberate sensitizations. 
Materials and Methods 
Animals and Technical ttandling.--These are described in the previous paper  (1), where 
methods used in tracing the  distribution of  1-a4C-picryl chloride (PCI*)  and of  14C-dinitro- 
chlorobenzene (DNCB*) following a single intradermal injection are given. 
Allergenic  Chemicals.--Picryl  chloride  (1  chloro-24,6-trinitrobenzene)  was  purchased 
from Eastman (Rochester, N.Y.) and recrystallized three times as a very faintly yellow product 
from a 2:1 mixture of absolute alcohol and benzene with use of Norit-A (mp 83  ° C).  Dinitro- 
chlorobenzene (1 chloro-2,4-dinitrobenzene) from Eastman was recrystallized from absolute 
alcohol with use of Norit-A (rap 500 C). Orthochlorobenzoyl chloride (o-C1BC1) was redistilled 
in vacuo (760-77 ° C  at 5-6 ram). 
Hapten-Protein  Conjugates.--Picrylated  casein  and  picrylated  guinea  pig  serum  were 
prepared essentially as in reference (8). They contained about 50 mg of picryl groupings per 
gram  of  protein. 
Fluorescein.--The  sodium  salt  of  fluorescein was  dissolved  in  buffered  saline  to  0.5% 
concentration and was then diluted further to 0.1 mg/ml. The intradermal dose was 0.02 ml. 
Experimental  Sensitization.--PC1  and  DNCB  were  diluted  from  2%  stock  solutions  in 
absolute alcohol (held cold in the dark) to 0.3% solutions in absolute alcohol. Dilutions into 
saline to give 2.5 #g/0.1 ml (8) were made, the solution then containing 0.83% of alcohol by 
volume. The solutions for injection were used immediately following dilution, the stock solu- 
tions were prepared every few weeks, o-C1BC1 (0.05 ml) was blended with olive oil (5 ml) and 
diluted further in olive oil by weight to give 100 #g/ml. The instability of o-C1BC1 in the 
presence of water required the use of an oil depot and a higher concentration of allergen. 10-12 
daily injections of 2.5 #g of picryl chloride in 0.1 ml of alcoholic saline were made seriatim 
along the flanks. By this means, changes occurring during the course of the injections, indi- 
cating onset of sensitivity, could be observed readily. In all instances, the animals were then 
rested for 14 days, and contact tests were applied. With o-C1BCI, 4 or 5 injections of 0.05 ml 
olive oil containing 5 #g sufficed  to sensitize. 
Double Sensitization.--To detect partial degrees of unresponsiveness towards picryl chloride, 
many experimental animals of the ear excision series were subjected to sensitization with the 
two allergens picryl chloride and o-chlorobenzoyl chloride. PC1 was injected in alcoholic saline 
as described above; o-C1BC1 was dissolved in olive oil and 0.05 ml containing 5/zg was injected 
intradermally. The two allergens were injected every other day in alternation. Since four or 
five injections of 5 #g of o-CIBC1 in olive oil sufficed  to sensitize, injections of o-C1BC1 were 
then stopped, and desired further PC1 applications were administered daily. In some  experi- 
ments sensitization to o-CIBC1 was induced after attempted sensitization to PCI. 
Contact Testing.--The procedure has been described previously (1). Test solutions, made in 
olive oil, were 1% PC1, 1% DNCB, and 8% o-C1BC1. All readings were read blindly by one of 
us (MWC) both at 24 and 48 hr. 
Passive Cutaneous Anaphylaxis  (PCA).--Serum or saline dilutions (0.1 ml volumes)  were 
injected intradermally into clipped areas on the back of normal albino guinea pigs  (220-280 g 
body weight). Each recipient guinea pig was also injected with a fixed dilution of a "standard 
serum" that, on the average, gave rise to a  16-18 mm reaction and represented 12 times the 
dilution-to-extinction concentration  for  the  average  guinea  pig.  (The  standard  allowed 
appraisal of the acceptability of the chosen recipient, and all reactions noted were  graded in 
terms of the response to the standard for the particular recipient. If the recipient gave dull re- ONSET O~' DELAYED SENSITMTY  AND  TOLERANCE  105 
actions, tests were carried to further recipients.) After the passage of 17 hr (a requirement for 
sera taken from guinea pigs sensitized with chemical allergens), intrajugular injection of 0.5 nag 
picrylated casein or 0.75 nag picrylated guinea pig serum proteins in 1 mi of saline was made, 
mixed with 0.5 to 0.7 ml of 0.5% Evans Blue (Wamer-Chilcott, Morris Plains, N. J.) according 
to body weight. Animals  were watched closely and final readings of blued areas were made after 
25 rain. 
Opera~ive Procedure~.--Operations were conducted under deep ether anesthesia.  Hair was 
clipped from the auricle and the immediate vicinity  of the scalp, and the area was sponged with 
70% ethanol. Ears were removed by sharp scalpel at their base, leaving two sharp lips of skin 
which were closed by sutures of three-twist linen thread. In other experiments areas of tissue 
were sometimes excised on the body wall. These were outlined on clipped skin by indelible 
pencil, about 1 cm caudal to one scapula and of hexagonal shape. The dorsoventral axis was 
35 rnm and the other axis was 20 mm in length.  (Within this area five in-line sites of 0.02 ml 
were injected, so that the outlined margin was equidistant from each site, with ample clearance 
to give assurance  of complete removal.)  The size of the area and of the volumes deposited 
were chosen after making studies with fluorescein. The skin margins were approximated, closed 
by 11 mm Michel wound clips (Propper Mfg. Co., Long Island City, N. Y.), and bandaged. 
Boots of adhesive tape were affaxed to the hind feet to prevent scratching movements. 
RESLFLTS 
Excision of Sites Injected on the Flank 
Initial experiments made use of the flank on which, within an outlined area as 
described under Materials and Methods, five sites of 0.02 ml were injected to 
deliver a total of 50/zg of picryl chloride. Extirpation was practiced after various 
times. 
In spite of the high dose delivered, sensitization was found to be completely 
blocked when the sites were excised within a period of 3 hr. Further lengthening 
of the time interval led to gradually increasing degrees of sensitivity, but exci- 
sions made even as late as 4 days seemed to depress sensitization slightly. 
These preliminary results were encouraging but the site was less well suited to 
a  quantitative study since erratic leakage due  to back  pressure  following re- 
moval of the needle caused uncertainty in the dosage actually introduced. 
It was desired both to reduce the total dose and to avoid back pressure leak- 
age. The ear proved to be suitable in this regard and it allowed ready removal 
with only minor surgery. To follow accurately the fate of radiotraced chemical 
allergens, it was desired to use nontoxic concentrations in an injection volume of 
only 0.01  ml and  to make only a  single injection. The dose finally chosen to 
allow sensitive appraisal of the comparative responses of animals of this stock of 
albino guinea pigs was 0.25 #g for PC1 and  approximately 5/zg for DNCB  (Fig. 
1). 
Effect of Excision of the Ear on Direct Sensitization 
When 0.25/~g of 2:4:6 trinitrochlorobenzene (picryl chloride, designated as 
PC1) in 0.01  ml was injected intradermally into the right ear and the ear was 
taken off 3 or 6 hr later, contact testing done on day 14 on 12 animals showed 106  EGON  MACIIER AND  MERRILL W. CHASE 
that sensitization had been blocked completely. With excisions carried out at 12 
or 24 or 48 hr after the single intradermal injection, the majority of the animals 
still did not respond to contact test, yet solitary animals became definitely sen- 
sitized. As the interval between injection and excision was lengthened further, 
the proportion of sensitive animals increased. 
The effect of removing ears at 12, 24, and 48 hr after the injection of PCI is shown 
in Fig. 2, lines A, B, and C. Omitted are the experimental groups on which the surgical 
extirpation was done at 6 hr or less and where sensitization consequently failed uni- 
formly. Fig. 2 shows five groups totalling 124 animals. The distribution of sensitivities 
in normal animals with intact ears, receiving the same dose of 0.25 #g of PC1, is shown 
I x0.25  p.g 
PCl 
I x0.25  p..g 
DNCB 
Ix5.0  p.g 
DNCB 
A  I 
I 
I 
I  !  " 
..  i  i:'..-i!"  !i  i  li 
B  i 
i 
•  I 
•  I 
I 
i  •  ! 
P99  9  • 
C  i 
I 
! 
! 
I 
I  *e  | 
i  •  +o  ell  ql  •  4 
0  +  +++  +++++ 
Fio.  1. Contact sensitivity  of controls. The mlnlmal sensitizing dosage is shown for two 
allergenic chemicals when injected into the ear (0.01 ml volume). Abscissa shows responses to 
contact testing. The vertical dashed line corresponds to a rating slightly below "one plus" and 
divides adequately  the population into essential nonresponders on the left and responders on 
the right.  Effective doses were 0.25 #g for picryl chloride (PC1) and 5/zg for dinitrochloro- 
benzene (DNCB). A dose of 0.25 ~g DCNB was ineffective. 
in line E.  Of the 20  animals,  4  essentially were not sensitized  and  12 became well 
sensitized, as expected (Fig. 1). Injected with only half of this dose, 20 normal animals 
with intact ears (Fig. 2, line D)  showed lowered sensitivities with five animals well 
sensitized and six low-to-moderately sensitized. The gradual shift towards increasing 
sensitivity as longer time is allowed is well illustrated: indeed, the 48 hr period before 
extirpation  is strongly suggestive of "half-effectiveness" of the dose used  (line  D). 
Excisions of the ear performed as late as 3 or 4 days after the sensitizing injection 
suggested some slight  disturbance  of sensitization,  but the numbers of animals in- 
volved were not sufficiently large to provide adequate data of extirpation effects at 
these times.  (No suppression of sensitization could be detected when the normal left 
ear was removed to imitate  the nonspecific effects of trauma the chemical allergen 
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Parallel experiments were made with 5.0 ttg of DNCB, excision being prac- 
ticed at 12, 24, 36, and 48 hr on 10 animals each. Removal of the ear at 12 hr 
inhibited sensitization of nearly every individual; with later excisions, gradually 
increasing numbers of animals responded with mild sensitization, rather earlier 
than when 0.25  ttg of picryl chloride was used. This result is consonant with 
the larger residue of DNCB retained in the ear with this higher dosage (refer- 
ence 1, Fig. 8)  although a  qualitative difference is not excluded. 
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FIG. 2.  Sensitivity following site excision. All animals excepting those in  row D  were 
injected in one ear with 0.25 ~tg PC1 in 0.01 ml; animals in row D  received half this dose. 
Surgical excision of the ear was practiced in 84 animals at stated times (rows A, B, C), 60 of 
these constituting a single experiment. 2 wk later, contact tests of 1% PCI in olive oil were 
applied to all animals. Responses  to contact testing are indicated on the abscissa. 
The Tolerogenic Effect of Excision of Ear Sites 
Animals found not sensitized after surgical excision of the ears as previously 
described may reflect either a virginal immunologic status owing to well-timed 
removal of the effective allergen or a state of actual suppression of sensitization 
by a  mechanism which  leads  to  immunological unresponsiveness.  To decide 
between these alternatives, all animals which had given no definitely positive 
response upon primary contact testing at 14 days (reactions less than  "one- 
plus")  were subsequently  subjected  to  secondary treatments  of  10-12  daily 
intradermal injections of 2.5 ttg PC1 in 0.1 ml of alcoholic saline. Final contact 108  EGON  M.ACHER  AND  MERRILL  W.  CHASE 
tests with PC1 were then made to ascertain whether the animals had undergone 
specific sensitization.  Since it  soon became  evident  that  a  depression  in  the 
degree of sensitivity,  rather  than  "all-or-none" sensitization  was to be meas- 
ured;  sensitization  towards  a  chemically  unrelated  allergen  o-chlorobenzoyl 
chloride (termed o-C1BC1), was generally, though not uniformly, attempted as 
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FIO. 3. Tolerogenic effect of excision of injection sites. The near plane  (animaIs indicated 
in closed circles) depicts animals shown in Fig. 2, rows A, B, C, having sensitivities below 
"one plus."  The far plane  (animals indicated in open circles) shows the distribution  of the 
animals, and of newly introduced controls (row D), following 10 daily injections of 2.5 #g of 
PCI in 0.1 ml saline into the skin and applying a contact test of I% PCI in olive oil 2 wk later. 
well. The procedure involved injections of the two chemical allergens on alter- 
nate  days  as described  in  Materials  and  Methods,  but in  some experiments 
sensitization  to  o-CIBC1 was  undertaken  after  attempted  sensitization  with 
PC1.  Animals  responding  weakly  to  PC1  (<  +)  and  well  to  o-C1BCI (> 
+  +-t-) were considered to be specifically tolerant to PC1. 
Fig. 3 illustrates the results of attempting to induce active sensitization in the non- 
responders shown in Fig. 2. In the foreground (solid black circles)  are shown, in lines ONSET OF DELAYED SENSITIVITY AND TOLERANCE  109 
A, B, and C, the nonresponders of Fig. 2. In the background (open drcles) are shown 
the sensitivities attained by these because of the sensitizing procedure, together with 
the responses of a newly introduced control group (line D). Owing to the use of 10-12 
daily injections instead of the single injection as shown in Fig. 2, 18 of the 20 animals 
of the control group are seen to be highly sensitive. In contrast, the average sensitivity 
attained  in  the  various  groups from which  the injection  sites  had  been  removed 
showed a significantly lower average sensitivity. About 50% of the animals remained 
unresponsive to a  second and more rigorous attempt to sensitize.  As their suscepti- 
bility  to sensitization  with  o-C1BCI was found undisturbed,  they were assessed  as 
being specifically tolerant to PCI because of the ear excisions. 
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1~o. 4. Tolerogenic effect of nonsensitizing doses. Near and far planes have same signifi- 
cance as in Fig. 3. The near plane (closed circles) shows result of contact testing with 1% PCI 
in olive oil 2 wk after injection of the nonsensitizing dose of 0.0125 #g PCI (row A). The far 
plane  (open circles) shows the distribution  of sensitivities of the same animals, and of newly 
introduced controls (row B), following active sensitization as in Fig. 3. 
Animals which had shown evidence of tolerance following site excision  and a sub- 
sequent active course of sensitization were test-bled to determine whether they had 
responded by antibody production. The sera were tested by passive cutaneous ana- 
phylaxis as described under Materials and Methods. Six control animals were found to 
have anti-picryl antibody ranging from 90-960 absolute units/& 1 mh In contrast, nine 
samples taken from animals having ears excised at 6, 12, or 24 hr after injection of 0.25 
pg PC1 were devoid of PCA antibody in seven cases, and the two others showed 2 and 6 
units. 
Animals found to be nonresponders owing to ear excisions after injection of 
5.0 #g of DNCB were likewise found to exhibit full or partial tolerance in about 
the same pattern as in Fig. 3. 
The Tolerogenlc Effect of Nonsensitizing Doses 
It  seemed likely that  the mechanism leading  to unresponsiveness  operated 
also when the doses of allergen were too low to sensitize. Indeed, when PC1 was 
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injected intradermally in an 0.0125 #g dose, which is practically nonsensitizing 
(Fig. 4, top row, closed circles), 50% of the animals turned out to be tolerant 
(open circles) after a series of sensitizing injections, and the average sensitivity 
attained by the whole group was much lower than that of the controls (Fig. 4, 
bottom row). 
Similar findings were made with DNCB, which, as pointed out in reference 1 
(Figs. 7 and 8), leaves the skin with great readiness and consequently requires 
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1~o. 5. Toleroge~ic effect of allergen escaping from  ear tissue. Near and faz planes have 
significance as in Fig. 3. The near plane (closed circles) indicates sensitivkies 2 wk after injec- 
tion of DNCB  (intradermally in row A, intravenously in row B) upon contact testing with 
1% DNCB in olive oil 2 wk later. The far plane (open  circles) shows distribution of the same 
animals, and of newly introduced controls (row C), following active sensitization with 10 
dally injections of 2.5 #g of DNCB and a contact test of 1% DNCB in olive oil 2 wk later, 
in manner used with PC1 in Fig. 3. 
an amount approaching 5#g to sensitize in  a  single injection (0.01  ml).  We 
therefore chose the nonsensitizing dose of 0.25 #g to study its possible tolero- 
genic effect. Fig. 5 shows (top row) that about haft of the animals injected intra- 
dermally with this nonsensitizing dose of DNCB and given a subsequent series 
of intradermal injections for active sensitization (open circles) were found to be 
specifically tolerant upon contact testing. 
Since it was found that following injection of 0.25 #g of DNCB into the ear, 
approximately 90 % enters the blood within 1 hr (1), the effect of injecting this 
amount (0.22 #g) of DNCB directly into the blood stream was tested. As antici- ONSET  O1~  DELAYED  SENSITIVITY  AND  TOLERANCE  111 
pared, this injection failed to provoke sensitization in any of 15 animals (Fig. 5, 
row B, dosed circles), but later attempts to sensitize the animals by means of 
serial intradermal injections of DNCB showed that half were unresponsive (Fig. 
5, row B, open circles), quite in contrast with positive controls not pretreated 
(Fig. 5, row C). 
Other experiments, also, indicated the essential role played by partial tolerance in 
determining the eventual degree of contact sensitivity. An example is provided in Fig. 
6, which concerns the restraint imposed by even a single contact test of 1% PC1 in off 
on susceptibility to undergo sensitization of the delayed type. 21 normal animals were 
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Fzo. 6. Tolerogenic effects of topical application of picryl chloride. Near and far planes 
have the same significance as in Fig. 3. The near plane (closed circles) shows the negative or 
slight reactivities of 27 normal guinea pigs following a single contact of 1 droplet (0.02 ml) of 
1% PC1 in olive oil. (These animals were used as toxicity controls in several experiments of 
active sensitization.) The far plane (animals indicated in open circles) shows the distribution 
of sensitivities of the same animals (row A) and of 33 normal guinea pigs (row B) following 
active sensitization (in various paired experiments) and contact testing as in Fig. 3. 
so treated in the course of several experiments, in which they served to evaluate "toxic- 
ity" (the combined irritative effects of dipping, application of olive oil, and of chemi- 
cal) as a base line for evaluating results. In later experiments, these animals were given 
10 daffy intradermal injections of 2.5 #g PCI in saline,  and their final response to an- 
other similar contact test is shown as open circles  in Fig. 6, row A, along with the 
typical response  to sensitization of sets of paired normal controls. 15 (55%)  of the 
animals which had received the contact test, but only one (3%) of the control group, 
failed to become sensitized.  The proportional differences in distribution  of the two 
groups along the abscissa also points to partial tolerance in many of the other once 
tested animals. The occurrence of partial unresponsiveness that remains stabilized at 
intermediate levels of sensitization has been noted before (9). 
Even 5 ng of PC1 injected into flank or ear, placed in five simultaneous sites of 0.02 
ml, gave evidence of tolerance; the ear site was more effective, one-third of the animals 112  EGON  MACttER  AND  MERRILL  W.  CHASE 
being well tolerant. Again, about one-third of animals became well tolerant when 5 ng 
was injected at one time into flank skin, divided among 20 sites of 0.25 ng each. 
The important role played by tolerance has been encountered also in single individ- 
ual guinea pigs which had been part of other experimental groups but had themselves 
failed to develop sensitivity by the regimen employed. When later many of these were 
subjected to a series of sensitizing, intradermal injections, they failed to respond to new 
contact testing but responded quite well to sensitization with o-CIBC1. Consequently 
they can probably be classed as having been made tolerant by the original regimen. 
The Effect of Direct Injection into Lymph Nodes 
To test rigorously the effect of actual escape of picryl chloride via the lympha- 
tics, direct injection in 0.01  ml volumes was made into a  surgically exposed 
auricular lymph node in each of 20 guinea pigs. Of these, 8 received 0.25 #g of 
PC1 and the remainder 0.005/~g.  Contact testing 2 wk later showed only 4 ani- 
mals of the 20 definitely sensitive (++++~,  +±,  +±,  +:t:, respectively). 
Attempted active sensitization on all animals showed full tolerance in eight and 
intermediate sensitivity in three others. Evidently drainage via the lymphatics, 
as well as via the blood, established tolerance in a fair proportion of animals. 
DISCUSSION 
The Development of Contact Sensitivity 
As demonstrated (1), the intradermal injection of small but effective amounts 
of allergen established a site from which drainage occurred continuously but at 
decreasing rates. The initial rate of escape was indeed high: Mter injection into 
the ear of a 250 ng dose in a volume of 0.01 ml, 75 % of 1-14C picryl chloride 
(PC1)  and 99 % of l*C-dinitrochlorobenzene (DNCB) were gone at 12 hr. The 
sites were excised surgically at various times in order to study the effect of inter- 
ruption of the drainage process and to differentiate between the roles of dis- 
persed and residual allergen. The animals were later subjected to contact testing 
to determine whether they had become sensitized when varying periods of time 
were allowed before removal of the ear. Rather clear-cut results were obtained 
with the use of spaced excisions. 
These experiments suggested that sensitization in fact is established through 
that portion of the chemical allergen which becomes fixed for some days at the 
site of application. Separation of the ear completely prevented sensitization to 
PCI when the injection site was excised at 6 hr or less following deposition of 
0.25 ~g of the allergen. At this time, approximately 60 % of picryl chloride had 
already left the site via the blood vessels of the ear (reference 1, Fig. 7). When 
the site was removed at 12 hr, the dermal depot of the chemical then being re- 
duced to about one-quarter of its original concentration, only 1 out of 28 animals 
became sensitized (Fig. 2, row A). (Not more than 60 ng of picryl remained at 
the site at this time [1, Fig. 8], probably largely conjugated.) Further extension 
of the time interval between deposition of allergen and excision led to a gradual 
increase in the rate of sensitization, suggesting that the immunologic "informa- ONSET  OF  DELAYED  SENS~IV~Y  AND  TOLERANCE  113 
fion" available at the local site is picked up progressively (Fig. 2). The suppres- 
sing effect of ear excision following the sensitizing injection of PC1 appeared to 
be traceable up to 3 or 4 days with the system used. 
The noted marked suppression of sensitization owing to ear excision can not 
be due merely to diminishing the total dose injected (250 ng) by the amount lost 
by excision. By 6 hr, for example, only half the dose of PCI remains in  the ear, 
a time at which every animal escapes sensitization. Yet if the ear is not removed 
and only half the standard dose is injected intradermally (125 ng), satisfactory 
sensitivity is seen in about 25 % (Fig. 2, row D). It seems necessary to conclude 
that sensitization is blocked because ear excision deprives the animals of their 
required antigen potential which must be located in the site. Hence the fraction 
of the chemical that escapes early must be considered irrelevant for sensitiza- 
tion. This fraction is discussed below. 
Peripheral Sensitization.--These  results support the concept of interaction 
between allergen and host tissue at the site as being essential for transformation 
of the  simple chemical into  the sensitizing antigen.  The sensitizing antigen, 
formed and fixed locally, is apparently the chemical depot found retained--but 
decreasingly--at the site between 12 and 96 hr after sensitizing doses have been 
applied (1). Such a depot was not established when a nousensitizing dose was 
used. 
Thus only the portion of the chemical that remains in situ becomes allergenic; the 
antigen seems to be sessile as suggested by the excisions performed at later stages. We 
have referred (1) in this connection to Medawar's concept of "peripheral sensitiza- 
tion," which is strongly affirmed by our present findings and which has been advanced 
also by Turk (7). Blood-borne lymphocytes would enter the site of the fixed antigenic 
structure and there undergo a  "training" experience;  then, homing in the draining 
node(s) and undergoing donal multiplication,  a group of cells would arise which react 
to a structure that they themselves have never met. If the depot is trivial and is re- 
presented by too little alteration of the sessile "carrier" structure--as happens with 
injection of 0.25/~g  of DNCB  (1) and probably of all nonsensitizing  doses such as 
0.0125/~g of PC1 (Fig. 4)--no adequate training field will be furnished.  The training 
field set up by one injection  of 250 ng of PC1 or by somewhat less than 5 ~g of DNCB is 
adequate to sensitize two-thirds of individuals, while the use of 125 ng of PC1 reduces 
the effectiveness still more (Fig. 2, row D). In both cases the spectrum of sensitivities 
(Fig. 1, rows A and C) apparently emphasizes the genetic diversity of the animals. 
Excisions of the site show that the number of animals sensitized increases pro- 
gressively with the time during which the host is exposed to the allergenic com- 
plex. These results resemble closely the gradual development of transplantation 
immunity shown to occur by Converse, Ballantyne, and Woisky (10) in an ex- 
perimental design in which ears containing a first set graft were excised after 
increasing intervals of time and second grafts from the same donors were sub- 
sequenfly placed on the other ears. 
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sitization was blocked completely or markedly when the ear site was removed at 
any time up to 24 hr (Fig. 2, row B) and highly significantly up to 48 hr. Normal 
sensitization was found surely only after 4 days. Other workers, applying larger 
amounts of allergen epicutaneously, have not been able to block sensitization for 
so long a time after site excision. At varying times, Frey and Wenk (2) excised 
4 X 3 cm fields of lower flank skin on which 2 ul of acetone containing 0.4-1.0 mg 
DNCB on a 3 mm circle had been deposited. Excision up to 8 hr stopped sensi- 
tization almost regularly but by 24 hr nearly normal sensitization would ensue, 
as seen by contact tests made on day 10. Turk and Stone (5), applying 20 to 200 
~I of solvents containing either 5 mg DNFB or 10 mg DNCB or 20 mg of oxa- 
zolone on one ear could prevent sensitization by site excision only within 2 hr; 
ear removal at 8 hr found 40 % of the animals sensitive and at 24 hr, 100 %. 
(Contact tests on animals becoming sensitive were increasingly positive from 5 
through 9 days.) In our own studies, just one apparent exception to a participa- 
tion of locally fixed allergen was noted in a group of 12 animals which received 
five simultaneous injections of 0.02 ml in one ear, delivering 50 #g of PC1, the 
ears being excised only 5 min later. Sensitization in 9 out of 12 was not prevented 
by this early excision, the animals behaving much like the paired 12 animals in 
which the ear was left intact. Apparently with this high dose of PC1 and the 
selection of ear  tissue,  a  sensitizing complex must be  established elsewhere. 
While this particular experiment should be repeated, it does not seem likely that 
the area of primary injection must always constitute the training field. The con- 
ditions that should be needed for establishing fixed depots of allergen would 
include:  (a)  an initial high local concentration of free hapten not dispersed 
rapidly in blood;1 (b) an insoluble structure chemically suited for coupling, be it 
collagen, precollagen, reticular fibers, or the like; (c) sufficient time for complex- 
ing; and (d) proximity to blood vessels from which lymphocytes would arrive. 
In Turk's report of preventing sensitization by excisions that were made when 
only 2-4 hr had elapsed, it does not seem likely that time would be afforded for 
coupling of hapten with a sessile carrier and for arrival and training of lympho- 
cytes. Accordingly, participation of other "fields" would be indicated under a 
concept of peripheral sensitization. Our own experiment points clearly to the 
full sufficiency of peripheral sensitization in a situation where allergen does not 
flood the organism. 
Role of Lymph Nodes.--Several types of experiments have indicated the need 
of patent lymphatics for onset of sensitization. Thus in earlier experiments of 
Landsteiner and Chase (12), patent lymphatics were required for initiating de- 
layed sensitivity when ivy extract was applied on an isolated skin island. Not 
conceived then, the alternative explanation of peripheral sensitization and use 
of the lymphatic pathway for passage of newly "informed"  cells into regional 
1  For coupling of hapten in situ, information available on picryl chloride indicates that 
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nodes now seems likely. Also, later and highly refined experiments of Frey and 
Wenk (2, 3) emphasized a role for the lymphatics. These workers isolated skin 
areas that had as the sole connection to the body a stalk of tissue containing a 
patent lymphatic channel only; such animals could be sensitized upon applica- 
tion of allergen to the explant. 
In our experiments, it was found that a direct lymphatic pathway was not 
needed, for surgical removal of the draining auricular node, done without disrup- 
tion of the blood supply to the ear, failed to inhibit sensitization in the slightest 
degree irrespective of removal made beforehand, or 15 rain,  3 hr, or 6 hr after 
injection of 0.25/~g of PC1 into that ear. This finding would appear to run coun- 
ter to a report by Frey and Wenk, but the difference may well be explained by 
technical procedure. These workers (2-4) revealed a key role for the regional 
nodes in that sensitization is prevented if the regional lymph nodes are excised 
either prior to the sensitizing  application of DNCB (2) or 2 days after the appli- 
cation (4). But they extirpated the entire inguinal fat pad and interrupted com- 
pletely the lymphatic drainage system, whereas our practice of removing just 
the immediate draining node in the chain of regional  nodes could not block all 
alternate lymphatic pathways. Unlike ourselves, Turk and Stone (5, d. 7) re- 
ported that they could cancd sensitization by removing the draining ear nodes 
at any time up to 3 days even though ear excision failed to block sensitization 
after 2 hr,  as mentioned above. What happened to increase the apparent im- 
portance of the local node for sensitization when the huge amount of allergen 
was  applied  to  the  ear  (5,  7)  can  not  be  interpreted  at  the  moment. 
These workers found small amounts of soluble,  TCA-precipitable hapten-pro- 
tein complexes to exist widespread in lymphatic tissue for more than 72 hr. We 
view these complexes  as representing  the same material  (but naturally in in- 
creased amount) which we find to leave the local site quickly and to be dissemi- 
nated by blood. Coupling must occur eventually; and we would not view the 
soluble carrier necessarily as "skin protein." 
When ready escape of antigen is possible, even early excisions can be ineffec- 
tual in preventing sensitization.  Microbial antigens suspended in saline escaped 
from an intradermal  site within a few seconds,  as revealed by excision  of the 
injection site, even when made "instantaneously," i.e., at 10 sec (13, 14, cf. 15). 
Freund and Lipton (16) made intracutaneous injections of spinal cord suspen- 
sion in a water-in-oil  emulsion containing killed tubercle bacilli and found that 
excision of the site at 1 hr still led to allergic encephalomyelitis and sensitization 
to tuberculin. This suggests that paraffan oil, the continuous phase, plays some 
special  role, for histologic  examination demonstrated that a portion of the in- 
jected material reached the regional  lymph nodes within that  time.  In their 
special case, namely, the spread of antigen within a paraffin oil menstruum con- 
taining mycobacteria, delayed sensitivity was destined to result regardless of the 
new site of lodgement. (In our work introduction of the chemical by most extra- 
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The Development of Tolerance 
The fraction of allergen which escapes from the site early plays an immuno- 
logically active role of a  different type, although obviously it is not used in 
sensitization. In analyzing the extent and effect of escape in animals on which 
early excisions of the site had been practiced, it was noted that about 50 % of the 
animals could not respond normally in subsequent deliberate attempts to sen- 
sitize them3 The state of tolerance was shown to be immunologically  specific, as 
the capability of the animals to become sensitized to an unrelated chemical 
allergen, orthochlorobenzoyl chloride, was not impaired. Whether the remaining 
50 % of the animals which did respond to the secondary sensitizing treatments 
had  never  received adequate immunologic stimulation from the  amount of 
chemical allergen escaping from the ear, or whether their degree of tolerance was 
broken by the subsequent sensitizing injection, can not be decided with cer- 
tainty with the system used, Here it is necessary to point out genetic differences 
between animals in their readiness for sensitization, as exemplified in Fig. 1, row 
C, and in Fig. 2, rows D and E. Amounts of allergen that constitute ineffective 
stimuli for most animals are entirely adequate for sensitizing some individuals 
(Fig. 2, line D). Conversely, when it is desired to establish unresponsiveness by 
rather standardized procedures such as feeding chemical allergens, a few animals 
are discovered in which the procedure is less than perfectly efficient (9); still less 
efficiency was uncovered when intravenous injection of chemical allergens was 
practiced (9), for hereit was not possible topredict which animals were unrespon- 
sive until injections of allergen designed to establish active sensitization had 
been made and the actual status determined. Animals were divided easily into 
those  rendered  fully unresponsive  by intravenous injection  and  those  who 
escaped completely (9).  It would, consequently, be hazardous to assume that 
intradermal injections of chemical allergen effectively "break" some unknown 
and unassessable degree of tolerance that might be presumed to "exist" because 
some of their mates in the experiment could actually be shown to be tolerant. 
The tolerogenic effect arising as a consequence of site excision could be mi- 
micked by injecting subsensitizing doses into the ear, without any excision (Fig. 
1, row B; Fig. 4, line A; Fig. 5, line A; Fig. 6, line A), probably because this range 
of doses fails to establish a local depot (cf. reference 1). The tolerogenic effect 
can be secured as readily by direct injection of doses that are found to escape 
from intradermal sites via blood vessels (Fig. 5, row B, and reference 1). The 
evidence that the tolerogen, as it escapes from the ear, is found in the blood (1) 
is reinforced by the high degrees of tolerance secured by direct introduction of 
sUbsensitizing doses into the blood stream. 
Another example of the application of a dose that is usually nonsensitizing is 
2 Frey and Wenk (2) encountered, in their experiments on excision of epicutaneous sites, 
animals that were later determined to be "not sensitizable"; such animals (the number is not 
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provided by animals which had been included in contact testing as toxicity con- 
trols (Fig. 6). Their single epicutaneous experience by means of the contact test 
rendered about 50 % of them specifically tolerant. Experimental manipulations 
provided additional  evidence. Even intradermal  application  of subsensitizing 
doses, such as 5 ng introduced into flank or ear in multiple sites at one time, 
finds up to one-third of the animals  to be well tolerant and others capable of 
only intermediary sensitivity. 
Occasionally, even with methods accepted as wholly adequate for sensitizing 
with chemical allergens,  single animals  will escape from sensitization  (Fig. 5, 
row C, shows 1 nonsensitized animal out of 15; Fig. 6, row B, shows 1 out of 33). 
In several instances, such animals have been found to fail to respond only to the 
one sensitizer. Thus, genetic factors determine the final result as well. Such ani- 
mals can be regarded either as difficult to sensitize or easy to make tolerant. 
Partial  unresponsiveness  is,  therefore,  established  in  a  variety  of ways in 
which small doses of allergen are introduced without stimulating  the onset of 
delayed sensitivity: practicing site excision, injecting directly into lymphatics or 
blood, applying subsensitizing doses to ear or flank, making single contact tests 
as seen here (Fig. 6) or reported previously (9, 21, 22), or making intravenous 
injections of 0.5-2.0 mg directly (9), or two spaced injections of 0.15 mg into 
mesenteric veins (23). By these several means, animals may show themselves to 
be well tolerant. In Figs. 3-5, attainment of an intermediate level of sensitivity 
(+ to -F+) was attained by 20% of the 126 animals which were subjected to 
tolerogenic influence and by 10.9%  of 55 normal  controls when all had been 
given 10 daily injections of 2.5 #g of PC1 (or DNCB) and finally a contact test. 
It was not practicable to determine how many of these 25 experimental (or the 6 
control) animals had become stabilized at an intermediate level of sensitivity, 
i.e., how many would exhibit only their prior degree of sensitivity after a further 
sensitizing  course had  been given later  on.  Stabilized  intermediary  levels of 
sensitivity (partial tolerance) have been encountered before, even utilizing three 
spaced, successive attempts to sensitize (9).  8 
It is interesting  to record that  a  few actively sensitized  "positive control" 
animals which did not express high sensitization failed also to increase in sen- 
sitivity when a further  sensitizing  course was given. Either  the animals  were 
exhibiting partial tolerance at the time of their first test or the later injections 
contributed  to the state. The mechanism underlying  establishment  of specific 
unresponsiveness to chemical allergens is not known. Since most of the chemical 
allergens in general are toxic in larger amounts, since methods must be employed 
that will avoid sensitization,  and since feeding, even rather liberally, actually 
introduces only small amounts beyond the gut wall (9), tolerance established 
s It is to be understood here that all attempts to sensitize were courses of intradermal injec- 
tions of the allergen. More rigorous methods can convert  even well-tolerant animals to some 
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with chemical allergens should be regarded as perhaps equivalent to "low-zone" 
paralysis described by Mitchison (24, 25) with induction of protein tolerance by 
means of minute doses. In the case represented  by allergenic chemicals, un- 
responsiveness or tolerance lasts for 11-13 months (9). 
As could have been  expected  from previous  experience  (26, 27), tolerance 
induced with allergenic chemicals to suppress delayed sensitivity also affects the 
antibody-synthesizing mechanism.  This was found to hold in the present in- 
stance when sera were examined from animals which had become tolerant (ear 
excision method). No PCA antibody was found in bleedings of seven animals 
and only 2 and 6 units in two others,  whereas control animals showed 90-960 
units (per 0.1 nil). The state of tolerance can not be construed to mirror what 
has been described as immune deviation (28, 29). That portion of the allergen 
which leaves the local site earliest  (and in high amount) might, if it could be 
traced further, reveal the cellular localization of the tolerogen. Such localization 
would have to be compared  carefully with the localization  of hapten-protein 
complexes which stimulate antibody formation when the ear is left intact. In our 
experiments, given the specific radioactivity  available and the low doses deliber- 
ately selected, subsequent localization  of the allergenic grouping  could not be 
traced. 
CONCLUSIONS 
Excision of the  intradermal injection  site,  used as  a tool  of  investigation,  has 
made it obvious that during the induction period of contact sensitivity  two 
immunologic processes  are occurring  simultaneously and independently, which 
in principle  act antagonistically.  From these  findings,  sensitization  to simple 
chem/cal compounds can be interpreted  as a process in which tolerogenic  and 
allergenic  stimuli  compete with one another. 
The resultant sensitization  would then be a measure of the balance attained 
between the two processes. The participation of tolerance  is shown clearly by 
ear excisions, in which further drainage and effectiveness of the allergenic depot 
are cancelled abruptly, leaving evident the tolerogenic role of the escaped por- 
tion, but many other examples of it have been provided in the intact animal. 
The balance attained between tolerance and sensitization is influenced by the 
given dose, as a low dose leads to a high rate of tolerance and somewhat larger 
doses lead to a high rate of sensitization.  As the dose is increased,  tolerance is 
either decreased or masked. Tolerance appears to become more dominant and 
complete as initial contacts with an allergen are made by nonsensitizing routes, 
even with higher dosage (feeding, intravenous injection) and, in instances pre- 
sented here, with rather low dosage given intravenously, or directly  into a lymph 
node. Tolerance must enter into, and to some extent modify, many and perhaps 
all instances of sensitization arising from the use of simple free allergenic com- 
pounds.  The proportional influence of tolerance will probably be greater the 
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A state of partial tolerance was observed in some individuals, apart from those 
animals in which a  high degree of tolerance was expressed.  The existence of 
partial tolerance could be interpreted as a resultant of two opposite forces--the 
tolerogenic effect secured by the preparative manipulation and the sensitizing 
effect of large amounts of allergen. 
The tolerogenic fraction of allergen travels rapidly in the blood and is thereby 
disseminated.  At  this  early  stage  it  is  probably chiefly free  allergen,  sub- 
sequently becoming bound covalently to various proteins and peptides or hydro- 
lyzed to picric acid or dinitrophenol. Material appears shortly in the urine which 
is not free allergen.  It is interesting to  note  that  the  thymus,  someties con- 
sidered as controlling tolerance, was always free of radioactivity; any amount 
present above 1 ng would have been detectable. 
SUM'MARY 
In light of knowledge of the rate and route of dispersal of allergenic chemicals 
from ear sites (0.25 pg of picryl chloride, or 2:4 dinitrochlorobenzene in 0.25 #g 
and 5.0 #g amounts), dispersal was interrupted at selected times by ear excision. 
The animals  exposed in this manner to different,  tiny amounts of allergen were 
tested for development of contact type hypersensitivity. 
Both of these allergenic chemicals left the local ear site in about three phases 
of successively lengthening "half-lives." In the first phase, the escape rate was 
high. The principal pathway of escape was not via the lymphatics but via the 
blood vessels.  Ear excisions made at 24 hr after injection of 0.25 #g of picryl 
chloride  (PC1) or at  12  hr  after injection of 5.0 #g of dinitrochiorobenzene 
(DNCB) essentially blocked onset of delayed type hypersensitivity, hence the 
first fraction to escape (80% of PC1, 98% of DNCB) was not used for sensitiza- 
tion. This large fraction serves rather to set up a state of specific tolerance,  for 
these individuals showed extensive deficits in their ability to respond to a later 
sensitizing  course.  Also the ability to form hapten-specific antibody appeared 
nearly completely suppressed. Injections of allergen  into the blood stream or 
directly in auricular nodes, in an amount approximating  that which escaped 
early from the ear, also led to the same degrees of unresponsiveness--sometimes 
full,  sometimes partial  tolerance.  The  same types of specific  tolerance were 
secured also by injecting subsensitizing doses into the ear, without excision, or 
into the flank and by contact tests applied to the flank. 
The allergen  remaining  in the ear after the early outflow, particularly be- 
tween 12-24 hr and 3-4 days, appeared to constitute the sensitizing  depot. The 
longer this depot was available to the animals the greater the immunological 
"information" for sensitization was picked up until the depot had served its 
full function around the 4th day. "Peripheral sensitization" was clearly demon- 
strable. 
The eventual degree of sensitivity attained by the animals was a resultant of 
two immunologic processes which occurred independently--tolerogenic effects 120  EGON  MACHER  AND  MERRILL  W. CHASE 
of escaped chemical on the one hand and on the other the sensitizing effect of 
the local sensitizing depot of allergen bound in the ear tissue. 
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